X-Chem | Latest News & Updates - Jan 10, 2025 Release
X-Chem has replaced its ArtemisAI platform with Integrated Computational Sciences and introduced HITMiner to enhance DEL data analysis...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡
X-Chem
🌎 x-chemrx.comX-Chem is a leading biotechnology research company specializing in small molecule drug discovery. Utilizing DNA-encoded chemical library (DEL) technology, discovery chemistry, and artificial intelligence, X-Chem provides comprehensive solutions for pharmaceutical and biotech companies. With a high success rate in identifying functional hits and a proven track record in various therapeutic targets, X-Chem is dedicated to advancing human health through innovative drug discovery services.
X-Chem - Latest News and Updates
- X-Chem has replaced its ArtemisAI platform with Integrated Computational Sciences and introduced HITMiner to enhance DEL data analysis.
- X-Chem is currently seeking a Director of Accounting & Finance in the United States.
- Calum Hand has left X-Chem, where he was a Consultant Research Scientist in the United Kingdom, to join Apheris as a Senior ML Field Engineer.
- Tatiana Demidova-Rice has joined X-Chem as Senior Director of Business Development.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.